ALZEX NEUROPHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1988 USD | -30.97% |
|
0.00% | -0.60% |
| 2015 | Trinity Resources Inc. will Change its Ticker to TRRI from TRLR.D | CI |
| 2013 | Trulan Resources Inc. to Acquire Additional Property Around its Existing IGP Iron-Gold-Platinum Project in Chile | CI |
More news
| 1 day | -30.97% | ||
| Current month | -30.97% | ||
| 1 month | -30.97% | ||
| 3 months | +28.26% | ||
| 6 months | -0.60% | ||
| Current year | -0.60% |
1 month
0.02
0.20
Current year
0.020.30
1 year
0.020.50
3 years
0.002.39
5 years
0.002.39
10 years
0.002.39
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Rosner
CEO | Chief Executive Officer | 59 | 10/12/10 |
| Director of Finance/CFO | 61 | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Rosner
CEO | Chief Executive Officer | 59 | 10/12/10 |
Alzex Neuropharma Inc., formerly Trinity Resources Inc., is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimerâs Disease but can be applied to other neurological diseases due to its platform technology.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| -0.60% | 299K | |
| +107.83% | 6.43B | |
| +98.02% | 1.25B | |
| +2.67% | 987M | |
| +20.03% | 785M | |
| +2.01% | 666M | |
| -2.15% | 593M | |
| -.--% | 600M | |
| +10.28% | 536M | |
| -.--% | 500M |
- Stock Market
- Equities
- TRRI Stock
